Liangjing Lu

3.2k total citations · 1 hit paper
106 papers, 2.2k citations indexed

About

Liangjing Lu is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Liangjing Lu has authored 106 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 40 papers in Immunology and 26 papers in Epidemiology. Recurrent topics in Liangjing Lu's work include Systemic Lupus Erythematosus Research (28 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Liangjing Lu is often cited by papers focused on Systemic Lupus Erythematosus Research (28 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Liangjing Lu collaborates with scholars based in China, United States and Philippines. Liangjing Lu's co-authors include Chunde Bao, Suke Li, Chengxiang Dai, Qiong Fu, Yang Song, Hui Du, Suli Wang, Lin Leng, Richard Bucala and Shun‐le Chen and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Liangjing Lu

94 papers receiving 2.2k citations

Hit Papers

Treatment of knee osteoarthritis with intra-articular inj... 2019 2026 2021 2023 2019 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial
    2019 184 citations Liangjing Lu, Ping Ye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangjing Lu China 28 1.1k 651 589 443 376 106 2.2k
Ji Eun Kim South Korea 30 692 0.7× 285 0.4× 955 1.6× 294 0.7× 566 1.5× 137 3.1k
Paola Di Benedetto Italy 32 574 0.5× 716 1.1× 849 1.4× 228 0.5× 280 0.7× 70 2.7k
Atsuyuki Igarashi Japan 31 707 0.7× 1.4k 2.2× 2.0k 3.3× 240 0.5× 151 0.4× 89 4.7k
Tiffany Caza United States 23 475 0.4× 667 1.0× 505 0.9× 185 0.4× 131 0.3× 76 2.0k
Michele Maria Luchetti Italy 26 678 0.6× 914 1.4× 709 1.2× 391 0.9× 120 0.3× 71 2.8k
Nemanja Damjanov Serbia 23 986 0.9× 410 0.6× 440 0.7× 166 0.4× 278 0.7× 95 2.3k
Kazuhiro Komura Japan 36 795 0.7× 1.3k 2.0× 833 1.4× 1.0k 2.4× 239 0.6× 79 3.9k
Vasiliki Liakouli Italy 34 645 0.6× 868 1.3× 852 1.4× 268 0.6× 303 0.8× 90 3.0k
John Varga United States 26 373 0.4× 334 0.5× 636 1.1× 284 0.6× 115 0.3× 49 2.0k
Agata Burska United Kingdom 21 602 0.6× 318 0.5× 299 0.5× 193 0.4× 221 0.6× 66 1.4k

Countries citing papers authored by Liangjing Lu

Since Specialization
Citations

This map shows the geographic impact of Liangjing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangjing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangjing Lu more than expected).

Fields of papers citing papers by Liangjing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangjing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangjing Lu. The network helps show where Liangjing Lu may publish in the future.

Co-authorship network of co-authors of Liangjing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Liangjing Lu. A scholar is included among the top collaborators of Liangjing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangjing Lu. Liangjing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Z., et al.. (2025). Hydroxychloroquine-Induced Acute Generalized Exanthematous Pustulosis. The Journal of Rheumatology. jrheum.2025–572.
2.
Lin, Wanyi, Zhigang Zhao, Fenglin Wu, et al.. (2025). Dual positivity for Anti-Ro52 and Anti-Ro60 antibodies is linked to greater organ involvement and disease progression in systemic sclerosis. Seminars in Arthritis and Rheumatism. 74. 152810–152810.
3.
4.
5.
Liu, Yaoyang, Zijian Kang, Shu‐Feng Zhou, et al.. (2023). Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 82(11). 1444–1454. 10 indexed citations
6.
Li, Jia, Yixuan Li, Jiaqi Feng, et al.. (2023). Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis. Clinical & Translational Immunology. 12(5). e1447–e1447. 15 indexed citations
7.
Yan, Qingran, et al.. (2023). Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer. Frontiers in Medicine. 10. 1113408–1113408. 1 indexed citations
8.
Zhou, Mi, et al.. (2022). Behcet’s-like disease in a patient treated with Ixekizumab for chronic plaque psoriasis. Scandinavian Journal of Rheumatology. 51(4). 336–337. 6 indexed citations
9.
Yang, Shaoying, et al.. (2022). Palmar-plantar erythrodysesthesia in lupus during pregnancy. QJM. 115(6). 417–419.
10.
Ling, Hanzhi, Man Li, Chenglin Yang, et al.. (2022). Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis. Lara D. Veeken. 61(11). 4521–4534. 85 indexed citations
11.
Zhang, Le, Shaoying Yang, Yongfu Yu, et al.. (2022). Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus. Hepatology Communications. 6(9). 2431–2440. 2 indexed citations
12.
13.
Li, Jia, Jun Li, Yuetian Yu, et al.. (2021). Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing. Rheumatology Advances in Practice. 6(1). rkab105–rkab105. 6 indexed citations
14.
Huang, Huijing, Xuesong Liu, Dandan Chen, et al.. (2020). Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α. International Immunopharmacology. 83. 106365–106365. 27 indexed citations
15.
Liu, Xuesong, et al.. (2020). The Role of RIPK1/3 in Adult Onset Still’s Disease Patients With Liver Damage: A Preliminary Study. Frontiers in Immunology. 11. 560744–560744. 6 indexed citations
16.
Yu, Yuetian, Hui Shen, Cheng Zhu, et al.. (2018). Infections Caused by Extended-Spectrum β-Lactamase Producing Escherichia Coli in Systemic Lupus Erythematosus Patients: Prevalence, Risk Factors, and Predictive Model. BioMed Research International. 2018. 1–9. 9 indexed citations
17.
Chen, Shujun, et al.. (2017). In vivo reflectance confocal microscopy in daily practice: Image features correlated to histopathology. Skin Research and Technology. 24(2). 223–228. 4 indexed citations
18.
Lu, Liangjing, Chunde Bao, Min Dai, et al.. (2009). Multicenter, randomized, double‐blind, controlled trial of treatment of active rheumatoid arthritis with T‐614 compared with methotrexate. Arthritis Care & Research. 61(7). 979–987. 58 indexed citations
19.
20.
Lu, Liangjing, Shun‐le Chen, Yueying Gu, et al.. (2003). Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cells.. Chinese Medical Journal. 116(3). 350–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Eun Kim Breakdown of academic impact, for papers by Paola Di Benedetto Breakdown of academic impact, for papers by Atsuyuki Igarashi Breakdown of academic impact, for papers by Tiffany Caza Breakdown of academic impact, for papers by Michele Maria Luchetti Breakdown of academic impact, for papers by Nemanja Damjanov Breakdown of academic impact, for papers by Kazuhiro Komura Breakdown of academic impact, for papers by Vasiliki Liakouli Breakdown of academic impact, for papers by John Varga Breakdown of academic impact, for papers by Agata Burska
Rankless by CCL
2026